A revised anchored version of the BPRS-C for childhood psychiatric disorders
A revised anchored version of the BPRS-C for childhood psychiatric disorders
复制标题
DOI：
10.1089/104454601750143500
复制
发表时间：
2001-03-01
影响因子：
1.9
通讯作者：
MacCabe, N
中科院分区：
文献类型：
--
作者：
Hughes, CW;Rintelmann, J;MacCabe, N
儿童简明精神病评定量表（BPRS-C）越来越多地被用作研究、管理式护理和公共部门儿童/青少年临床环境中的结果测量。制定BPRS-C是为了提供适用于广泛的儿童和青少年精神疾病的症状描述性特征。它的使用通常包括受过培训和未经培训的临床评估人员，他们在儿童和青少年疾病方面具有不同程度的经验和培训。不幸的是，后一种方法会导致大量的分数变化，从而降低其整体可靠性。本研究报告了修订后的BPRS-C，增加了临床描述性锚点，旨在提高经过培训和未经培训的评分者的可靠性和有效性。对10个公共部门设施中的4，733名儿童和青少年进行了BPRS-C沿着以及其他标准临床措施（儿童行为检查表和整体功能评估）。其他可靠性数据收集在大学医学中心的儿童和青少年研究网站与受过培训和未经培训的评分员。数据表明，改善整体的可靠性和有效性分数，良好的内部一致性，并提高因子得分。增加总体严重程度评分可能被证明是评估治疗反应的有用结局指标。
The Brief Psychiatric Rating Scale for Children (BPRS-C) is increasingly used as an outcome measure in research, managed care, and public sector child/adolescent clinical settings. The BPRS-C was developed to provide a descriptive profile of symptoms applicable to a broad range of child and adolescent psychiatric disorders. Its use frequently includes trained and untrained clinician raters with differing degrees of experience and training in child and adolescent disorders. Unfortunately, this latter approach leads to a large amount of variability in scores and consequently reduces its overall reliability. This study reports on a revised BPRS-C with the addition of clinical descriptive anchors designed to improve reliability and validity for both trained and untrained raters. A sample of 4,733 children and adolescents seen in 10 public sector facilities was administered the BPRS-C along with other standard clinical measures (Child Behavior Checklist and Global Assessment of Functioning). Additional reliability data were gathered in a University Medical Center child and adolescent research site with both trained and untrained raters. The data indicated improvement in overall reliability and validity scores, good internal consistency, and improved factor scores. The addition of an overall total severity score may prove to be a useful outcome measure for assessment of treatment response.